Nj. Hargreaves et al., What causes smear-negative pulmonary tuberculosis in Malawi, an area of high HIV seroprevalence, INT J TUBE, 5(2), 2001, pp. 113-122
Citations number
48
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
SETTING: The Central Hospital and the District Tuberculosis (TB) Registry i
n Lilongwe, the capital of Malawi. In this setting smear-negative pulmonary
tuberculosis (PTB) is diagnosed using clinical and radiographic criteria f
or TB, and mycobacterial cultures are not routinely available.
OBJECTIVE: To determine the proportion of patients being registered for sme
ar-negative PTB treatment in Lilongwe who have TB that can be confirmed mic
robiologically.
DESIGN: Prospective cohort study of patients about to start treatment under
operational conditions for smear-negative PTB in Lilongwe between October
1997 and June 1998. Patients referred to the study team underwent a detaile
d clinical re-assessment, testing for human immunodeficiency virus (HIV), r
epeat sputum smear microscopy for acid-fast bacilli and mycobacterial cultu
res of sputum and blood. Bronchoscopy and bronchoalveolar lavage (BAL) were
performed and BAL fluid was examined for TB, Pneumocystis carinii and othe
r fungi.
RESULTS: Of 352 smear-negative PTB suspects assessed, the diagnosis of TB w
as confirmed in 137 (39%) cases. Eighty-nine per cent of patients assessed
were HIV-positive, of whom 81% met the expanded case definition for the acq
uired immune-deficiency syndrome (AIDS).
CONCLUSION: TB was the most commonly confirmed diagnosis amongst patients a
bout to start treatment for smear-negative PTB in an area of high backgroun
d HIV seroprevalence.